Page last updated: 2024-10-29

iomeprol and Lung Diseases, Interstitial

iomeprol has been researched along with Lung Diseases, Interstitial in 1 studies

iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Handra-Luca, A1

Other Studies

1 other study available for iomeprol and Lung Diseases, Interstitial

ArticleYear
Xanthomatous Interstitial Pneumopathy: Chemotherapy- or Contrast Substance Related Change?
    International journal of surgical pathology, 2020, Volume: 28, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Hu

2020